Replies to post #85284 on Innovation Pharmaceuticals Inc (IPIX)

[Ultimate01]

I don't have anything to offer but thats what brought me here and what keeps me excited.

We should have started the U of Bologna study by now, we should be receiving SPORE grant results by now and we should get updates for the latest cohort progression and any other agreements with universities out there.

***Lastly, Leo and Dr. Menon plan EVERYTHING out in great detail and have let us know that they expect MTD around this dosage so I also expect news of this any day now BUT Im very optimistic in that as long as there is some benefit to the patients that they will continue to receive treatment with K and that alone is reason for fireworks!

GO Patient X!!!!

[GregChase]

From the Dec 22nd PR


Biotech Showcase: Kevetrin and Prurisol

Cellceutix will be updating shareholders on the latest developments of the Kevetrin clinical trials for solid tumors ongoing at Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center and the upcoming trial of Kevetrin for Acute Myeloid Leukemia (AML) being sponsored by the University of Bologna and its partners during the Biotech Showcase conference being held in San Francisco on January 12, 2015. Updates on the Company's Phase 2 trial of Prurisol (abacavir acetate) for plaque psoriasis will also be provided at the conference.